Mendelian randomization combined with real-world study reveals that Streptococcus anginosus exacerbates dietary triglyceride metabolism disorders in obese mice
World Journal of Microbiology and Biotechnology · 2025
DOI: 10.1007/s11274-025-04558-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Microbiology and Biotechnology, 2025. Verfasst von Xian-Long Shu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, P. R. China. Hauptthemen laut MEDLINE: Triglycerides, Obesity, Streptococcus anginosus. Die Arbeit nennt 54 Literaturangaben. Gefördert von: National Natural Scientific Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Mendelian Randomization (MR) analysis can link the host gut microbiome to cardiovascular diseases. Streptococcus anginosus (S. anginosus) has been found to be positively correlated with early atherosclerosis, but its role in lipid metabolism remains to be explored. To investigate the impact of S. anginosus on lipid metabolism, we employed M methods using large-scale population genome-wide association study (GWAS) sequencing data, combined with a C57BL/6J mouse obesity model to assess the role of S. anginosus in lipid metabolism. Throughout the entire experiment, we monitored the dynamic changes in serum blood lipids in mice and the abundance of S. anginosus in feces. We evaluated the accumulation of lipid droplets in the liver and adipose tissue, as well as examined the gene-level expression changes of lipid metabolism enzymes and transcription factors. The findings from MR analysis indicate that ten specific gut microbial taxa including Streptococcaceae exhibit a causal relationship with disorders of lipoprotein metabolism. Notably, Streptococcaceae has been identified as a risk factor for it. Furthermore, S. anginosus has been shown to elevate serum triglycerides (TG) levels, diminish the accumulation of lipid droplets in both hepatic and adipose tissues, and downregulate the gene expression of enzymes involved in TG synthesis and metabolism. These findings suggest that S. anginosus is a risk factor for lipoprotein disorders and reduces dietary lipid metabolism in a mouse obesity model, leading to TG metabolism dysfunction. This study combines bioinformatics analysis and animal experiments to provide new insights into S. anginosus as a risk factor for lipid metabolism disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, P. R. China.
- Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha, 410078, P. R. China.
- Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, 110 Xiangya Road, Changsha, 410078, P. R. China.
- Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, P. R. China. 207082@csu.edu.cn.
- Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, 110 Xiangya Road, Changsha, 410078, P. R. China. 207082@csu.edu.cn.
- Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, P. R. China. jietang@csu.edu.cn.
Förderung
- National Natural Scientific Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Shu, X. L., Xie, J. L., Li, X., Wang, G., & Tang, J. (2025). Mendelian randomization combined with real-world study reveals that Streptococcus anginosus exacerbates dietary triglyceride metabolism disorders in obese mice. World Journal of Microbiology and Biotechnology. https://doi.org/10.1007/s11274-025-04558-6
Vancouver
Shu XL, Xie JL, Li X, Wang G, Tang J. Mendelian randomization combined with real-world study reveals that Streptococcus anginosus exacerbates dietary triglyceride metabolism disorders in obese mice. World Journal of Microbiology and Biotechnology. 2025. doi:10.1007/s11274-025-04558-6
BibTeX
@article{Shu2025,
author = {Shu, Xian-Long and Xie, Jia-Ling and Li, Xi and Wang, Guo and Tang, Jie},
title = {Mendelian randomization combined with real-world study reveals that Streptococcus anginosus exacerbates dietary triglyceride metabolism disorders in obese mice},
journal = {World Journal of Microbiology and Biotechnology},
year = {2025},
doi = {10.1007/s11274-025-04558-6}
}
EUVIMED